All In Biotech

Drug Trial Radar · NCT03656744

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM

Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 101 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

101

Actual

Start

Nov 26, 2018

Primary completion

Feb 7, 2020

Study completion Mar 9, 2020

Sponsor

Sponsor type
Industry
First posted
Sep 4, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, double-blind, placebo-controlled, parallel-group study comparing multiple doses of HTD1801 to placebo.

Conditions

  • Fatty Liver, Nonalcoholic
  • NAFLD
  • Nonalcoholic Fatty Liver Disease
  • Nonalcoholic Steatohepatitis
  • Digestive System Diseases
  • Type 2 Diabetes Mellitus (T2DM)

Interventions

  • HTD1801Drug

    HTD1801 tablets, 250mg

  • PlaceboDrug

    tablets manufactured to mimic HTD1801 tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change in Liver Fat Content (LFC) as Measured by MRI-PDFFTime frame: Baseline through study Week 18

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Institute for Liver Health

    Chandler, Arizona

  • Institute for Liver Health

    Tucson, Arizona

  • Adobe Clinical Research

    Tucson, Arizona

  • National Research Institute

    Panorama City, California

  • Excel Medical Clinical Trials

    Boca Raton, Florida

  • Florida Research Institute

    Lakewood Rch, Florida

  • Compass Research

    Orlando, Florida

  • Kansas City Research Institute

    Kansas City, Missouri

  • Cumberland Research Associates

    Fayetteville, North Carolina

  • Gastro One

    Germantown, Tennessee

  • Digestive Health Research

    Hermitage, Tennessee

  • Pinnacle Clinical Research

    Austin, Texas

  • Doctors Hospital at Renaissance

    Edinburg, Texas

  • Pinnacle Clinical Research

    San Antonio, Texas

  • Texas Digestive Disease Consultants

    Southlake, Texas

  • Harborview Medical Center

    Seattle, Washington

  • University of Washington Medical Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.